LIMN
Liminatus Pharma, Inc. Class A Common Stock
$0.65
-0.06
(-8.6%)
| Exchange: | |
| Market Cap: | 17.514M |
| Shares Outstanding: | 34.5M |
About The Company
| Sector: | Healthcare | |||||
| Industry: | Biotechnology | |||||
| CEO: | Chris Kim | |||||
| Full Time Employees: | 3 | |||||
| Address: |
|
|||||
| Website: | https://liminatuspharma.com |
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.
Click to read more…
Revenue Segmentation
EPS
Earnings Call
Income Statement
(* All numbers are in thousands)
Balance Sheet
(* All numbers are in thousands)
Cash Flow Statement
(* All numbers are in thousands)
Analyst Estimates
(* All numbers are in thousands)
